Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer von DI MAIO, Massimo, CHIODINI, Paolo, PERRONE, Francesco, GRIDELLI, Cesare, GEORGOULIAS, Vassilis, HATZIDAKI, Dora, TAKEDA, Koji, WACHTERS, Floris M, GEBBIA, Vittorio, SMIT, Egbert F, MORABITO, Alessandro, GALLO, Ciro

Volltext

Selective targeting of homologous DNA recombination repair by gemcitabine von Wachters, Floris M, van Putten, John W.G, Maring, Jan G, Zdzienicka, Malgorzata Z, Groen, Harry J.M, Kampinga, Harm H

Volltext

Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: A prognostic score from individual data of nine randomised trials von Di Maio, Massimo, Lama, Nicola, Morabito, Alessandro, Smit, Egbert F, Georgoulias, Vassilis, Takeda, Koji, Quoix, Elisabeth, Hatzidaki, Dora, Wachters, Floris M, Gebbia, Vittorio, Tsai, Chun-Ming, Camps, Carlos, Schuette, Wolfgang, Chiodini, Paolo, Piccirillo, Maria Carmela, Perrone, Francesco, Gallo, Ciro, Gridelli, Cesare

Volltext

Cardiotoxicity in Advanced Non-small Cell Lung Cancer Patients Treated with Platinum and Non-platinum Based Combinations as First-line Treatment von WACHTERS, Floris M, VAN DER GRAAF, Winette T. A, GROEN, Harry J. M

Volltext

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism von Maring, Jan Gerard, Wachters, Floris M, Slijfer, Monique, Maurer, J. Marina, Boezen, H. Marike, Uges, Donald R. A, de Vries, Elisabeth G. E, Groen, Harry J. M

Volltext

Phase II study of docetaxel and carboplatin as second-line treatment in NSCLC von Wachters, Floris M, van Putten, John W.G, Boezen, H.Marike, Groen, Harry J.M

Volltext

Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC von DODDE, Wilma I. W, MARING, Jan Gerard, HENDRIKS, Gert, WACHTERS, Floris M, GROEN, Harry J. M, DE VRIES, Elisabeth G. E, UGES, Donald R. A

Volltext